Photo of Renjith Vijayakumar Selvarani from researchgate.net
Jun 25, 2025, 14:06
Renjith Vijayakumar Selvarani: An Indian-based startup OLUSIUM is breaking new ground in cancer diagnostics
Renjith Vijayakumar Selvarani, Founder, Chairman, Chief Scientific and Technology Officer at OLUSIUM, shared a post on LinkedIn:
“An Indian-based startup OLUSIUM is breaking new ground in cancer diagnostics!
A highly accurate, early stage, real time, label free, cost effective multi-cancer detection test that can identify asymptomatic cancers and deliver digital pathology results on time. This means:
Faster patient turnaround with real-time insights
– No labels or markers required
– Lower costs for broader access
– Early detection when treatment can be most effectivePilot and early multicentric validation have shown extremely promising results – and we’re just getting started!
bring better, faster, and more affordable cancer detection to patients everywhere.”
More posts featuring Renjith Vijayakumar Selvarani on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 25, 2025, 20:58
Aug 25, 2025, 20:44
Aug 25, 2025, 20:33
Aug 25, 2025, 19:54
Aug 25, 2025, 19:00
Aug 25, 2025, 17:36